All In Biotech

Drug Trial Radar · NCT00545753

Safety and Efficacy Study of NatrOVA Creme Rinse - 1% and NIX Creme Rinse in Subjects 6 Months or Older With Head Lice

A Phase 3 Comparative Safety and Efficacy Study Between NatrOVA Creme Rinse - 1% and NIX Creme Rinse in Subjects >6 Months of Age or Older With Pediculosis Capitis

Last checked: Nov 20, 2026Latest source record: Oct 11, 2012 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 558 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

558

Actual

Start

Sep 2007

Primary completion

Mar 2008

Study completion May 2008

Sponsor

Lead sponsor
ParaPRO LLCIndustry
Sponsor type
Industry
First posted
Oct 17, 2007

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 6 months
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

A comparative safety and efficacy study of NatrOVA Creme Rinse - 1% versus NIX Creme Rinse, under actual use conditions in subjects 6 months of age or greater who are infested with Pediculosis capitis (human head lice).

Conditions

  • Pediculosis

Interventions

  • SpinosadDrug

    10 minute topical application product, following by a complete rinse off.

  • SpinosadDrug

    10 minute topical application followed by a complete rinse off, followed by a nit combing regimen

  • Permethrin 1%Drug

    Topical application for 10 minutes, followed by a complete rinse off, followed by a nit combing regimen

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Efficacy of NatrOVA Creme Rinse - 1% Relative to NIX Creme Rinse in Subjects Infested With Head LiceTime frame: Assessment were made 14 days following the final product treatment

Locations

6 sites in 1 country. Site status is shown where the registry gives one.

  • Hill Top Research

    Scottsdale, Arizona

  • Burke Pharmaceutical Research

    Hot Springs, Arkansas

  • Impact Clinical Trials

    Beverly Hills, California

  • DMI Healthcare Group

    Largo, Florida

  • Hill Top Research

    Miamiville, Ohio

  • Haber Dermatology & Cosmetic Surgery

    South Euclid, Ohio

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.